0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
67 Ansichten2 Seiten
HNPCC o Most common hereditary colon cancer o Bathesda guidelines and Amsterdam critera provide diagnostic guidelines for HNPCC Not predictive in up to 30% of all cases o Autosomal dominant mismatch repair o Highly conserved process fond in prokaryotes and eukaryotes mismatch repair gene repairs mismatches Error in this leads to accumulations of errorcancer Polymorphism o when a DNA sequence variation causes no significant effect on phenotype
Originalbeschreibung:
Originaltitel
People That Meet Clinical Criterion Synonymous Differences
HNPCC o Most common hereditary colon cancer o Bathesda guidelines and Amsterdam critera provide diagnostic guidelines for HNPCC Not predictive in up to 30% of all cases o Autosomal dominant mismatch repair o Highly conserved process fond in prokaryotes and eukaryotes mismatch repair gene repairs mismatches Error in this leads to accumulations of errorcancer Polymorphism o when a DNA sequence variation causes no significant effect on phenotype
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als DOC, PDF, TXT herunterladen oder online auf Scribd lesen
HNPCC o Most common hereditary colon cancer o Bathesda guidelines and Amsterdam critera provide diagnostic guidelines for HNPCC Not predictive in up to 30% of all cases o Autosomal dominant mismatch repair o Highly conserved process fond in prokaryotes and eukaryotes mismatch repair gene repairs mismatches Error in this leads to accumulations of errorcancer Polymorphism o when a DNA sequence variation causes no significant effect on phenotype
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als DOC, PDF, TXT herunterladen oder online auf Scribd lesen
o Bathesda guidelines and Amsterdam critera provide diagnostic guidelines for HNPCC Not predictive in up to 30% of all cases o Autosomal dominant • Mismatch repair o Highly conserved process fond in prokaryotes and eukaryotes o Both copies of mismatch-repair gene must be mutated to develop cancer Can inherit one bad copy then have somatic mutation that affects second • Does not predict cancer perfectly • Where this mutation occurs dictates where cancer will reside Mismatch repair gene repairs mismatches • Error in this leads to accumulations of errorcancer • Polymorphism o When a DNA sequence variation causes no significant effect on phenotype o May influence height and hair color rather than characteristics of medical importance o When identify a variationmust determine whether or not it is detrimental Achieved via comparing variations to the Human Mutation Database • Marfan Syndrome o Autosomal dominant o Majority of mutations in FBN1 gene Mutation found in 90% of people that meet clinical criterion • Synonymous differences o Differences in the nucleotide level that do not translate into differences at the amino acid level o Can occur in Marfan’s where genetic testing may show mutation but individual does not exhibit clinical manifestations consistent w/ disease • Non-synonymous o Affect the sequence of the resultant protein o Likely to result in a change in phenotype or to be associated with a disease • Hemolytic Anemia o Fetal HB 2alpha2epsilon o Adult HB 2apha2beta • Alpha Thalassemia’s occur when people have mutation in the alpha hemoglobin genes Silent carrier state-don’t see effect Hemoglobin H disease-lack of fxn alpha protein is great enough to cause anemia and serious health problems Alpha thatlassemia major • No fxn alpha genes exist • Beta Thalassemia o Caused by mutation affecting the production of beta globin proteins o Found in people with mediteranean descent o Major form results in anemia • Sickle Cell Anemia o Mutation of the B-globin gene o Codes for HbS which is an aggregating form of HB o Glutamatevaline substitution • Sickle beta thalassemia o Inherit both beta thalassemia and sickle hemoglobin s mutation o Have reduced amounts of beta protein as well as abnormal s hemoglobin • Point Mutation o Cause 95% of b thalassemia’s and 5% of alpha thalassemias • Persistent fetal HB + sickle cell disease=no symptoms